相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2020 WHO Classification What's New in Soft Tissue Tumor Pathology?
Michael E. Kallen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Ewing-like sarcoma: An emerging family of round cell sarcomas
Samuele Renzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis
Yan Ma et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival
Zachary R. Gallegos et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy
Alexandre V. Hirayama et al.
BLOOD (2019)
Emerging trends in immunotherapy for pediatric sarcomas
Kyle A. Dyson et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Julian Staniek et al.
FRONTIERS IN IMMUNOLOGY (2019)
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Dana L. Casey et al.
FRONTIERS IN ONCOLOGY (2019)
Advances in immune checkpoint inhibitors for bone sarcoma therapy
Pichaya Thanindratarn et al.
JOURNAL OF BONE ONCOLOGY (2019)
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
Keri A. Streby et al.
MOLECULAR THERAPY (2019)
Prognostic profiling of the immune cell microenvironment in Ewing?s Sarcoma Family of Tumors
David Stahl et al.
ONCOIMMUNOLOGY (2019)
Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
Christian Spurny et al.
PEDIATRIC BLOOD & CANCER (2018)
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype
Simone Borgoni et al.
ONCOIMMUNOLOGY (2018)
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
Jan Remsik et al.
BRITISH JOURNAL OF CANCER (2018)
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
Philipp Berning et al.
CELL COMMUNICATION AND SIGNALING (2018)
Emerging Targeted and Immune-Based Therapies in Sarcoma
Seth M. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The expansion of targetable biomarkers for CAR T cell therapy
Michelle H. Townsend et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma
Barbara Kunzler Souza et al.
MOLECULAR NEUROBIOLOGY (2018)
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)
Robin E. Norris et al.
PEDIATRIC BLOOD & CANCER (2018)
Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT)
Isidro Machado et al.
VIRCHOWS ARCHIV (2018)
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
Christian Spurny et al.
Oncotarget (2018)
CD99 at the crossroads of physiology and pathology
Michela Pasello et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma
Sarah E. Bosma et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
Nicholas L. Denton et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
Ashwini Balakrishnan et al.
CLINICAL CANCER RESEARCH (2017)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
Sareetha Kailayangiri et al.
ONCOIMMUNOLOGY (2017)
Preclinical development of novel humanised ROR1 targeting chimeric antigen receptor T cells and bispecific T-cell engagers
Satyen Gohil et al.
LANCET (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology
Kentaro Igarashi et al.
ONCOTARGET (2017)
Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent
Anke E. M. van Erp et al.
ONCOTARGET (2017)
The neoepitope landscape in pediatric cancers
Ti-Cheng Chang et al.
GENOME MEDICINE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
Takaaki Nakai et al.
CANCER MEDICINE (2017)
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors
Satyen Harish Gohil et al.
ONCOIMMUNOLOGY (2017)
Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo
Andreas Kirschner et al.
ONCOIMMUNOLOGY (2017)
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells
Uwe Thiel et al.
ONCOIMMUNOLOGY (2017)
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins
Krishna Priya Thangaretnam et al.
SCIENTIFIC REPORTS (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Jay M. Lee et al.
CLINICAL CANCER RESEARCH (2017)
Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients
Keri A. Streby et al.
CLINICAL CANCER RESEARCH (2017)
Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
Laurens G. L. Sand et al.
BMC CANCER (2017)
Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney A Rare and Lethal Entity
Romulo Celli et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Srinivas Malladi et al.
CELL (2016)
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2016)
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
Konstantin Dobrenkov et al.
PEDIATRIC BLOOD & CANCER (2016)
Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target
Jennifer Town et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report
Jorge Hernando-Cubero et al.
ONCOLOGY LETTERS (2016)
Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growth in vitro and in vivo
Franziska Blaeschke et al.
ONCOTARGET (2016)
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Adrienne H. Long et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity
David Schirmer et al.
ONCOIMMUNOLOGY (2016)
Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
Nicholas L. Denton et al.
BIOMEDICINES (2016)
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment
W. Hans Meisen et al.
CLINICAL CANCER RESEARCH (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
Michael Y. Choi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway
Florian Engert et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2015)
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
Timothy P. Cripe et al.
MOLECULAR THERAPY (2015)
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
Tsion Zewdu Minas et al.
ONCOTARGET (2015)
CXCR4 over-expression and survival in cancer: A system review and meta-analysis
Hongli Zhao et al.
ONCOTARGET (2015)
IGF1R-and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Xin Huang et al.
PLOS ONE (2015)
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
Carolina Berger et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
Edwin Choy et al.
BMC CANCER (2014)
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals
Bianca Altvater et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth
Patrick J. Grohar et al.
CLINICAL CANCER RESEARCH (2014)
Therapeutic cell carriers: a potential road to cure glioma
Jacob S. Young et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Round cell sarcomas beyond Ewing: emerging entities
Cristina Antonescu
HISTOPATHOLOGY (2014)
Epithelial-Mesenchymal Transition Enhances Response to Oncolytic Herpesviral Therapy Through Nectin-1
Chun-Hao Chen et al.
HUMAN GENE THERAPY (2014)
EWS/FLI-1 peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model
Wei Peng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus
Emma Spurrell et al.
JOURNAL OF VIROLOGY (2014)
Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF-κB-Dependent Autophagy
Laura Shulak et al.
JOURNAL OF VIROLOGY (2014)
Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma
Melanie A. Krook et al.
MOLECULAR CANCER RESEARCH (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis
Claudia Buehnemann et al.
PLOS ONE (2014)
The Lymphoid Chemokine CCL21 Enhances the Cytotoxic T Lymphocyte-Inducing Functions of Dendritic Cells
C. Y. Hong et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
WT1 regulates angiogenesis in Ewing Sarcoma
Varalakshmi Katuri et al.
ONCOTARGET (2014)
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
Elena Garcia-Martinez et al.
BREAST CANCER RESEARCH (2014)
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Hua Zhang et al.
BLOOD (2013)
Characterization of Ewing sarcoma associated cancer/testis antigens
Dorothea E. Mahlendorf et al.
CANCER BIOLOGY & THERAPY (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
Bing Cui et al.
CANCER RESEARCH (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
S. Sankar et al.
ONCOGENE (2013)
Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture
Maximilian Ackermann et al.
ANGIOGENESIS (2012)
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients
T. G. P. Grunewald et al.
ANNALS OF ONCOLOGY (2012)
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
S. Kailayangiri et al.
BRITISH JOURNAL OF CANCER (2012)
PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
J. Chad Brenner et al.
CANCER RESEARCH (2012)
EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors
Christopher H. Evans et al.
CLINICAL CANCER RESEARCH (2012)
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Balveen Kaur et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas
Antoine Italiano et al.
GENES CHROMOSOMES & CANCER (2012)
The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas
Cassandra Graham et al.
HUMAN PATHOLOGY (2012)
Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
Nai-Kong V. Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
Suman Malempati et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
Melinda S. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies
Hema Dave et al.
PLOS ONE (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
NATURE REVIEWS CANCER (2012)
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
Dagmar Berghuis et al.
CLINICAL SARCOMA RESEARCH (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
U. Thiel et al.
BRITISH JOURNAL OF CANCER (2011)
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix
Walayat Shah et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Dan G. Duda et al.
CLINICAL CANCER RESEARCH (2011)
WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia
Gregory McCarty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
Heribert Juergens et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2011)
Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma
Idriss M. Bennani-Baiti et al.
JOURNAL OF PATHOLOGY (2011)
Prognostic Significance of HLA Class I Expression in Ewing's Sarcoma Family of Tumors
Hiroki Yabe et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma
E. Pardali et al.
ONCOGENE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H. A. Wakelee et al.
ANNALS OF ONCOLOGY (2010)
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells
Liu Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
Michael Hudecek et al.
BLOOD (2010)
Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling
Brian Tomkowicz et al.
CANCER BIOLOGY & THERAPY (2010)
Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing's Sarcoma
Idriss M. Bennani-Baiti et al.
CLINICAL CANCER RESEARCH (2010)
Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts
Saral S. Desai et al.
INDIAN JOURNAL OF ORTHOPAEDICS (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ewing's Sarcoma: Standard and Experimental Treatment Options
Vivek Subbiah et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2009)
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Elspeth Beauchamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2009)
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
Hayriye V. Erkizan et al.
NATURE MEDICINE (2009)
Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors
Aiko Suminoe et al.
PEDIATRIC TRANSPLANTATION (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells
Sven Christian et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells
Nicolo Riggi et al.
CANCER RESEARCH (2008)
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
Crystal L. Mackall et al.
CLINICAL CANCER RESEARCH (2008)
High expression of neuropeptide Y1 receptors in Ewing sarcoma tumors
Meike Koerner et al.
CLINICAL CANCER RESEARCH (2008)
Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
Cecile Rouleau et al.
CLINICAL CANCER RESEARCH (2008)
Final results of a Phase I/II study of CTCE-9908, a novel anticancer agent that inhibits CXCR4, in patients with advanced solid cancers
S. J. Hotte et al.
EJC SUPPLEMENTS (2008)
Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor
Krishna Reddy et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal,antigen and receptor for Wnt5a
Tetsuya Fukuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
Treatment of metastatuc Ewing Sarcoma/Primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy - A report from the children's oncology group
James S. Miser et al.
PEDIATRIC BLOOD & CANCER (2007)
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration
Brian Tomkowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells
Juergen Sonnemann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti-vascular endothelial growth factor receptor-2 therapy
Zhichao Zhou et al.
CLINICAL CANCER RESEARCH (2007)
NPY receptors in human cancer:: A review of current knowledge
Meike Koerner et al.
PEPTIDES (2007)
Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR
Joannes F. M. Jacobs et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma
Silvia Mateo-Lozano et al.
CLINICAL CANCER RESEARCH (2006)
Generation of tumoricidal PAX3 peptide antigen specific cytotoxic T lymphocytes
David A. Rodeberg et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A
Jeffrey A. Toretsky et al.
CANCER RESEARCH (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells
N Riggi et al.
CANCER RESEARCH (2005)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia
DWJ van der Schaft et al.
CANCER RESEARCH (2005)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
S Hu-Lieskovan et al.
CANCER RESEARCH (2005)
Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors
R Sakimura et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma
A Maksimenko et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Identification of an immunogenic EWS-FLI1-derived HLA-DR-restricted T helper cell epitope
F Meyer-Wentrup et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model
H Guan et al.
CLINICAL CANCER RESEARCH (2005)
Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources
NS Lipman et al.
ILAR JOURNAL (2005)
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
CS Mitsiades et al.
CANCER CELL (2004)
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
F Marchesi et al.
CANCER RESEARCH (2004)
Characterization of tissue specific expression of Notch-1 in human tissues
A Baldi et al.
BIOLOGY OF THE CELL (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Tumor expression of 4-1BB ligand sustains tumor lytic T cells
H Zhang et al.
CANCER BIOLOGY & THERAPY (2003)
Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a model
H Kovar et al.
SEMINARS IN CANCER BIOLOGY (2003)
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues
JC Lo et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors
DF Carpentieri et al.
MODERN PATHOLOGY (2002)
The XAGE family of cancer/testis-associated genes:: Alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma
AJW Zendman et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter-institute NIH study
R Dagher et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
HU Kontny et al.
CELL DEATH AND DIFFERENTIATION (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
HLA class I expression on human cancer cells - Implications for effective immunotherapy
BD Tait
HUMAN IMMUNOLOGY (2000)
分享论文
